|
Cabazitaxel multiple rechallenge in metastatic castration-resistant prostate cancer: A therapeutic option to increase overall survival? |
|
|
No Relationships to Disclose |
|
|
Speakers' Bureau - Sanofi |
Travel, Accommodations, Expenses - Mundipharma |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Ipsen; Janssen-Cilag; MSD Oncology; Roche |
Travel, Accommodations, Expenses - Astellas Pharma; Janssen Oncology; Novartis; Pfizer; pfizer |
|
|
Consulting or Advisory Role - Sanofi |
Travel, Accommodations, Expenses - Amgen; Biogaran Pharmaceuticals; Ipsen; Novartis |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - GlaxoSmithKline |
|
|
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen; MSD |
Travel, Accommodations, Expenses - BMSi; Janssen; Sanofi |
|
|
Honoraria - Astellas Pharma; EUSA Pharma |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Pfizer; Roche |
|
|
Honoraria - Astellas Pharma; Janssen; Roche; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Janssen; Roche; Sanofi |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD Oncology; MSD Oncology; Novartis; Pfizer; Roche; Roche; Sanofi |
Research Funding - Ipsen; Sanofi |
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck; MSD Oncology; Novartis; Pfizer; Roche |